BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $84 at Oppenheimer
October 28, 2021 6:20 AM
Oppenheimer analyst Leland Gershell raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $84.00 (from $81.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
